World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
37958
World Ranking
17802
National Ranking
1614

Nicholas D. James publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nicholas D. James sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 445 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Nicholas D. James D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nicholas D. James sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Nicholas D. James is affiliated with the Institute of Cancer Research in the United Kingdom. Their research focus is situated primarily in the field of Medicine, with a strong emphasis on oncology and cancer-related studies. The scientist has contributed extensively to subfields such as Pulmonary and Respiratory Medicine, Surgery, Oncology, Radiology, Nuclear Medicine and Imaging, and Cancer Research.

Their work largely addresses topics in cancer treatments and diagnosis, particularly relating to prostate and bladder cancers. Major themes in their publications include:

  • Prostate Cancer Treatment and Research
  • Bladder and Urothelial Cancer Treatments
  • Prostate Cancer Diagnosis and Treatment
  • Radiopharmaceutical Chemistry and Applications
  • Urinary and Genital Oncology Studies
  • Cancer, Lipids, and Metabolism
  • Cancer Immunotherapy and Biomarkers

Among their recent publications are the following significant papers:

  • The Lancet Commission on prostate cancer: planning for the surge in cases (2024, The Lancet)
  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 (2020, European Urology)
  • Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial (2020, The Lancet)
  • Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials (2021, The Lancet Oncology)
  • Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 (2023, European Journal of Cancer)

Nicholas D. James has collaborated frequently with several co-authors, including:

  • Noel W. Clarke
  • Matthew R. Sydes
  • Gerhardt Attard
  • Mahesh Parmar
  • Silke Gillessen

Their publications appear regularly in prominent journals, highlighting active engagement in the clinical oncology community. The most frequent publication venues include:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • European Urology
  • European Urology Oncology
  • The Journal of Urology

Best Publications

  • Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

    Ian F. Tannock;Ronald de Wit;William R. Berry;Jozsef Horti

  • Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

    C. Parker;S. Nilsson;S. Nilsson;D. Heinrich;S. I. Helle

  • Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

    Nicholas D. James;Johann S. de Bono;Melissa R. Spears;Noel W. Clarke

  • Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

    Nicholas D. James;Nicholas D. James;Matthew R. Sydes;Noel W. Clarke;Malcolm David Mason

  • Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.

    Christopher C Parker;Nicholas D James;Christopher D Brawley;Noel W Clarke

  • Radiotherapy with or without Chemotherapy in muscle-invasive bladder cancer

    Nicholas D. James;Syed A. Hussain;Peter Jenkins;Jean Tremlett

  • The auxin influx carrier LAX3 promotes lateral root emergence

    Kamal Swarup;Eva Benková;Eva Benková;Ranjan Swarup;Ilda Casimiro

  • A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

    Maria Carmen Marin;Christine A. Jost;Louise A. Brooks;Meredith S. Irwin

  • A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor

    Jennifer C.C. Hu;Robert S. Coffin;Ceri J. Davis;Nicola J. Graham

  • Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

    Oliver Sartor;Robert E Coleman;Sten Nilsson;Daniel Heinrich

  • Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

    Nicholas David James;Melissa R. Spears;Noel W. Clarke;David P. Dearnaley

  • AUX/LAX Genes Encode a Family of Auxin Influx Transporters That Perform Distinct Functions during Arabidopsis Development

    Benjamin Péret;Kamal Swarup;Alison Ferguson;Malvika Seth

  • Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

    Claire L. Vale;Sarah Burdett;Larysa H. M. Rydzewska;Laurence Albiges

  • Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy : the SPARC trial

    Cora N. Sternberg;Daniel P. Petrylak;Oliver Sartor;J. Alfred Witjes

  • NASCArrays : a repository for microarray data generated by NASC's transcriptomics service

    David J. Craigon;Nick James;John Okyere;Janet Higgins

  • Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

    S Gillessen;A Omlin;G Attard;J S de Bono

  • Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.

    N.W. Clarke;A. Ali;F.C. Ingleby;A. Hoyle

  • Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer : a systematic review

    Guillaume Ploussard;Siamak Daneshmand;Jason A. Efstathiou;Harry W. Herr

  • Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis

    S. C. Hillman;D. J. McMullan;G. Hall;F. S. Togneri

  • Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial

    Christopher C Parker;Noel W Clarke;Adrian D Cook;Howard G Kynaston

Frequent Co-Authors

Matthew R. Sydes
Matthew R. Sydes University College London
Noel W. Clarke
Noel W. Clarke University of Salford
Chris Parker
Chris Parker Institute of Cancer Research
Malcolm David Mason
Malcolm David Mason Cardiff University
Maurice P. Zeegers
Maurice P. Zeegers Maastricht University
David P. Dearnaley
David P. Dearnaley Institute of Cancer Research
Mahesh K. B. Parmar
Mahesh K. B. Parmar University College London
Robert Huddart
Robert Huddart Institute of Cancer Research
Silke Gillessen
Silke Gillessen Universita della Svizzera Italiana
Gerhardt Attard
Gerhardt Attard University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t always require following the traditional path to becoming a medical doctor. A range of online degree options now enables students to pursue diverse health-related careers, often in more affordable and flexible ways.

For nurses seeking leadership roles, enrolling in one of the cheapest dnp programs can open doors to advanced clinical practice and administration. Pharmacists can gain their credentials through accredited online pharmd programs, allowing them to balance work while furthering their education.

If you’re interested in the administrative side of healthcare, consider an online rhit degree programs that focus on health information technology and patient data management. Additionally, medical billing and coding online courses offer a quick route into a high-demand healthcare field—perfect for those seeking flexible, entry-level opportunities.

These online degrees and courses provide accessible options for starting or advancing your healthcare career in the US, often with reduced tuition and flexible schedules.

Best Scientists Citing Nicholas D. James

Trending Scientists